|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Prasugrel#Patient Counseling Information]] |
| {{Prasugrel}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Patient Counseling Information==
| |
| | |
| ===Benefits and Risks===
| |
| | |
| Summarize the effectiveness features and potential side effects of Effient.
| |
| Tell patients to take Effient exactly as prescribed.
| |
| Remind patients not to discontinue Effient without first discussing it with the physician who prescribed Effient.
| |
| Recommend that patients read the Medication Guide.
| |
| | |
| ===Bleeding===
| |
| | |
| Inform patients that they:
| |
| | |
| will bruise and bleed more easily.
| |
| will take longer than usual to stop bleeding.
| |
| should report any unanticipated, prolonged, or excessive bleeding, or blood in their stool or urine.
| |
| | |
| ===Other Signs and Symptoms Requiring Medical Attention===
| |
| | |
| Inform patients that TTP is a rare but serious condition that has been reported with Effient.
| |
| Instruct patients to get prompt medical attention if they experience any of the following symptoms that cannot otherwise be explained: fever, weakness, extreme skin paleness, purple skin patches, yellowing of the skin or eyes, or neurological changes.
| |
| | |
| Inform patients that they may have hypersensitivity reactions including rash, angioedema, anaphylaxis, or other manifestations. Patients who have had hypersensitivity reactions to other thienopyridines may have hypersensitivity reactions to Effient.
| |
| | |
| ===Invasive Procedures===
| |
| | |
| Instruct patients to:
| |
| | |
| inform physicians and dentists that they are taking Effient before any invasive procedure is scheduled.
| |
| tell the doctor performing the invasive procedure to talk to the prescribing health care professional before stopping Effient.
| |
| | |
| ===Concomitant Medications===
| |
| | |
| Ask patients to list all prescription medications, over-the-counter medications, or dietary supplements they are taking or plan to take so the physician knows about other treatments that may affect bleeding risk (e.g., warfarin and NSAIDs).
| |
| | |
| Literature revised November 14, 2013
| |
| | |
| Effient® is a registered trademark of Eli Lilly and Company.
| |
| | |
| Manufactured by Eli Lilly and Company, Indianapolis, IN, 46285
| |
| | |
| Marketed by Daiichi Sankyo, Inc. and Lilly USA, LLC
| |
| | |
| Copyright ©2009, 2013 Daiichi Sankyo, Inc. and Eli Lilly and Company. All rights reserved.
| |
| | |
| PV 7804 AMP<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6 | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6 | publisher = | date = | accessdate = 6 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |